This compound is a difluorinated tetrahydrofuran derivative featuring two benzoate ester groups and a methylsulfonyloxy leaving group, configured with defined stereochemistry. It serves as a pharmaceutical intermediate for the synthesis of nucleoside analogs in research and development settings.
Область применения: Информация на этой странице относится к идентификации химических веществ и к контекстам промышленного снабжения, исследований и производства. Она не является терапевтическим заявлением, медицинской рекомендацией или инструкцией по применению лекарственных средств.
Закупаете или поставляете это соединение?
Разместите инвентарь или запрос на покупку
CAS 134877-42-2
1-O-Acetyl-3,5-bis (4-Chlorobenzoyl)-2-Deoxy-D-ribose
Pharmaceutical intermediate for nucleoside analogs
Uridine, 2'-deoxy-2'-fluoro-, 3',5'-diacetate
Pharmaceutical intermediate for nucleoside analogs
(2R,3R,5R)-5-(4-Amino-2-oxopyrimidin-1(2H)-yl)-2-((benzoyloxy)methyl)-4,4-difluorotetrahydrofuran-3-yl benzoate
Pharmaceutical intermediate for nucleoside analogs
6-(Benzyloxy)-9-((1S,3R,4S)-4-(benzyloxy)-3-((benzyloxy)methyl)-2-methylenecyclopentyl)-9H-purin-2-amine
Pharmaceutical intermediate for nucleoside analogs
1-(4-(1-(3,5,5,8,8-Pentamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)vinyl)phenyl)ethanone
Intermediate for bexarotene impurity synthesis
2-[2-(2-aminoethoxy)ethoxy]acetic acid;hydrochloride
Pharmaceutical intermediate for pegylation
(1S,5R)-8-Methyl-8-Azabicyclo(3.2.1)Octan-3-Ol
pharmaceutical intermediate
Dibenzyl (2S,4R)-4-hydroxypyrrolidine-1,2-dicarboxylate
protected proline derivative for peptide synthesis
[(2R,3R,5R)-3-benzoyloxy-4,4-difluoro-5-methylsulfonyloxyoxolan-2-yl]methyl benzoate
LIAQHZDWFACWFK-GPMSIDNRSA-N
CS(=O)(=O)O[C@@H]1C([C@@H]([C@H](O1)COC(=O)C2=CC=CC=C2)OC(=O)C3=CC=CC=C3)(F)F